Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
parp decrease » pa decreased (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
parp decrease » pa decreased (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
-
1
Inotodiol decreases clone formation in HCC cells.
Published 2025“…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …”
-
2
-
3
-
4
Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression.
Published 2024“…<p>(A) NEAT1 expression following siRNA transfection in BEAS-2B cells; (B-D) The expression of NEAT1, miR-204-5p, and Six1 after decreasing NEAT1 expression. * p <0.05, *** p < 0.001, and **** p <0.0001.…”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
PARP9 knockdown promotes apoptosis and DNA damage.
Published 2024“…(E) DNA damage in GC cells significantly increased post-PARP9 knockdown as determined by comet assay. (F) The anti-DNA damage capacity of GC cells decreased markedly following reduction of PARP9 expression. …”
-
12
-
13
-
14
-
15
A summary of the included study characteristics.
Published 2025“…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
16
-
17
-
18
-
19
-
20